Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation-Reference-Cited by-同舟云学术

Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation

Published:2021-10-08 Issue:1 Volume:57 Page:43-50
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kobayashi Shinichi,Kanda Yoshinobu^ORCID,Konuma Takaaki^ORCID,Inamoto Yoshihiro^ORCID,Matsumoto Kimikazu,Uchida Naoyuki^ORCID,Ikegame Kazuhiro^ORCID,Miyamoto Toshihiro,Doki Noriko,Nakamae Hirohisa,Katayama Yuta^ORCID,Takahashi Satoshi,Shiratori Souichi^ORCID,Saito Shoji,Kawakita Toshiro,Kanda Junya^ORCID,Fukuda Takahiro,Atsuta Yoshiko^ORCID,Kimura Fumihiko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01485-6.pdf

Reference32 articles.

1. Moukalled NM, Kharfan-Dabaja MA. What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia? Bone Marrow Transpl. 2020;55:325–31. https://doi.org/10.1038/s41409-019-0584-3. e-pub ahead of print 2019/06/05

2. Yanada M, Konuma T, Yamasaki S, Kondo T, Fukuda T, Shingai N, et al. Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes. Bone Marrow Transpl. 2021;56:1126–33. https://doi.org/10.1038/s41409-020-01163-z. e-pub ahead of print 2020/12/04

3. Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P, et al. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transpl. 2015;50:1542–50. https://doi.org/10.1038/bmt.2015.186. e-pub ahead of print 2015/09/15

4. Vrhovac R, Labopin M, Ciceri F, Finke J, Holler E, Tischer J, et al. Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. Bone Marrow Transpl. 2016;51:186–93. https://doi.org/10.1038/bmt.2015.221. e-pub ahead of print 2015/10/06

5. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transpl. 2004;34:721–7. https://doi.org/10.1038/sj.bmt.1704645. e-pub ahead of print 2004/08/24

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies;Annals of Hematology;2024-07-14

2. Advances in second hematopoietic stem cell transplantation;Frontiers in Immunology;2024-07-09

3. Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib;Hematology;2024-06-03

4. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

5. Signaling pathways governing the behaviors of leukemia stem cells;Genes & Diseases;2024-03